Identification of novel APP-specific alpha secretase in human umbilical cord blood sera
人脐带血血清中新型 APP 特异性 α 分泌酶的鉴定
基本信息
- 批准号:9380529
- 负责人:
- 金额:$ 22.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-15 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:Abeta synthesisAgeAlpha CellAlzheimer&aposs DiseaseAmyloidAmyloid beta-ProteinAmyloid beta-Protein PrecursorAntibodiesBrainCell-Free SystemCerebrumChinese Hamster Ovary CellCleaved cellComplexCuesCytokine ActivationDementiaDepositionDevelopmentDiagnosisDiseaseDisintegrinsDoseElderlyEnzymesExclusionFamily memberFrequenciesGoalsHumanHuman Amyloid Precursor ProteinImpaired cognitionImpairmentIndividualInflammatoryInfusion proceduresInjection of therapeutic agentInterleukin-1 betaInterleukin-6Ion-Exchange Chromatography ProcedureLengthLigationLinkMediatingMembraneMetalloproteasesMusNeurocognitionNeuronsPathogenesisPathologyPathway interactionsPeptidesPhagocytosisPhosphorylationPreparationPrevalenceProcessProductionProteolysisRecombinantsReportingSerumT-LymphocyteTNF geneTNFRSF5 geneTNFSF5 geneTherapeuticUmbilical Cord BloodUmbilical cord structureWorkZincagedalpha secretasebehavior testbehavioral impairmentbeta secretasebeta-site APP cleaving enzyme 1chemokinecognitive testingconditioned fearcytokineimprovedintraperitonealmonocyteneurogenesisneuron lossneuroprotectionnovelprophylacticrestorationsecretasetau Proteinstreatment strategytumor progressiontumorigenesis
项目摘要
Project Abstract
We have recently shown that sAPPα directly inhibits β-secretase (BACE1) proteolysis of APP, thereby
reducing Aβ production. In addition, our most recent studies show that sAPPα reduces Alzheimer’s disease
(AD)-related tau-hyper-phosphorylation by inhibition of GSK3β. Moreover, while multiple low dose infusions of
human umbilical cord blood-derived monocytes (CB-M) reduce AD pathology and behavioral impairment in
PSAPP mice, in part via phagocytosis of Aβ, aged monocytes show impaired Aβ phagocytosis, which can be
reversed by sAPPα. These results suggest that CB-M have their own α-secretase or activate endogenous α-
secretase in the PSAPP mice. Thus, restoration of sAPPα levels in the brain by shifting the amyloidogenic
towards the non-amyloidogenic (α-secretase) pathway could ameliorate AD-related amyloid and tau pathology,
neuronal loss and cognitive impairment. An increase in α-secretase activity, therefore, is an attractive strategy
for treatment of AD. Several years after descriptive reports on α-secretase, the responsible enzymes have
been identified as members of the family of A Disintegrin And Metalloproteinase (ADAM). Three of these
membrane-anchored zinc-dependent metalloproteinases, ADAM10, ADAM17 and ADAM9, possess α-
secretase activity. However, during the past years, numerous other substrates have been linked to all three
sheddases, some of which could promote AD pathogenesis via activation of cytokines or chemokines. Indeed
ADAM17 is also known as the TNFα converting enzyme (TACE), which releases TNFα, a proinflammatory
cytokine. It has also been reported that CD40L is released from T-cells via ADAM10 and 17 upon CD40
ligation. Furthermore, ADAM10 and ADAM17 are not APP-specific, cleave various substrates and have been
associated with tumorigenesis and tumor progression.
We have most recently found that human umbilical cord blood serum (CBS) markedly enhance APP α-
cleavage and thereby increase sAPPα production in CHO cells expressing wild-type human APP. In addition,
CBS selectively mediated the α-secretase cleavage of neuron-specific, human recombinant full-length APP695
(fAPP695) in a cell-free system, independent from TACE and ADAM10. We partially purified this α-secretase
using DEAE, preparative-grade size exclusion and further ion-exchange chromatography and the present
purified fraction (αCBS Frac.) dose-dependently cleaves fAPP695, also independent from TACE and ADAM10.
Importantly, αCBS Frac. does not cleave precursor pro-inflammatory cytokines, including IL-6 and TNFα.
Furthermore, treatment of 3XTg-AD mice with αCBS Frac by i.c.v. injection markedly increases cerebral
sAPPα levels together with significant decreases in cerebral Aβ production and abnormal tauThr231
phosphorylation. The ultimate goal of this proposal will be to further characterize the effects of αCBS Frac on
AD pathology and behavioral impairment in 3XTg-AD mice, which display both Aβ and tau pathology, and
ultimately identify and characterize this novel and APP specific α-secretase.
项目摘要
我们最近发现sAPPα直接抑制APP的β-分泌酶(BACE 1)蛋白水解,从而
减少Aβ的产生。此外,我们最近的研究表明,sAPPα减少阿尔茨海默病
通过抑制GSK 3 β的AD相关tau蛋白过度磷酸化。此外,虽然多次低剂量输注
人脐带血来源单核细胞(CB-M)减少AD病理和行为障碍
在PSAPP小鼠中,部分通过吞噬Aβ,老年单核细胞显示出受损的Aβ吞噬作用,这可能是
由sAPPα逆转。这些结果提示CB-M有自身的α-分泌酶或激活内源性α-分泌酶。
PSAPP小鼠中的分泌酶。因此,通过转移淀粉样蛋白原,
向非淀粉样蛋白生成(α-分泌酶)途径的转化可以改善AD相关的淀粉样蛋白和tau病理,
神经元丧失和认知障碍。因此,增加α-分泌酶活性是一种有吸引力的策略
治疗AD。在对α-分泌酶进行描述性报道几年后,
已被鉴定为A解整合素和金属蛋白酶(ADAM)家族的成员。其中三
膜锚定的锌依赖性金属蛋白酶,ADAM 10,ADAM 17和ADAM 9,具有α-
分泌酶活性然而,在过去的几年里,许多其他基板已连接到所有三个
脱落酶,其中一些可以通过激活细胞因子或趋化因子促进AD发病。确实
ADAM 17也被称为TNFα转化酶(TACE),它释放TNFα,一种促炎因子,
细胞因子也有报道称,CD 40 L通过ADAM 10和17从T细胞释放,
结扎此外,ADAM 10和ADAM 17不是APP特异性的,切割各种底物,并且已经被证实是APP特异性的。
与肿瘤发生和肿瘤进展相关。
我们最近发现,人脐带血血清(CBS)可显著增强APP α-
切割,从而增加表达野生型人APP的CHO细胞中sAPPα的产生。此外,
CBS选择性介导α-分泌酶切割神经元特异性人重组全长APP 695
(fAPP 695)在无细胞系统中,独立于TACE和ADAM 10。我们部分纯化了这种α-分泌酶
使用DEAE,纯化级尺寸排阻和进一步的离子交换色谱,
纯化组分(αCBS Frac.)剂量依赖性地切割fAPP 695,也独立于TACE和ADAM 10。
重要的是,αCBS Frac。不裂解前体促炎细胞因子,包括IL-6和TNFα。
此外,通过i. c. v.注射αCBS Frac治疗3XTg-AD小鼠,
sAPPα水平以及脑Aβ产生的显著减少和异常tauThr 231
磷酸化本提案的最终目标是进一步表征αCBS Frac对
3XTg-AD小鼠中的AD病理学和行为障碍,其显示Aβ和tau病理学,以及
最终鉴定和表征这种新型APP特异性α-分泌酶。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jun Tan其他文献
Jun Tan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jun Tan', 18)}}的其他基金
A flavonoid gamma-secretase modulator (GSM) reduces beta-amyloid and tau pathologies in the AD mice
类黄酮 γ 分泌酶调节剂 (GSM) 可减少 AD 小鼠的 β-淀粉样蛋白和 tau 蛋白病理
- 批准号:
9127058 - 财政年份:2015
- 资助金额:
$ 22.43万 - 项目类别:
A flavonoid gamma-secretase modulator (GSM) reduces beta-amyloid and tau pathologies in the AD mice
类黄酮 γ 分泌酶调节剂 (GSM) 可减少 AD 小鼠的 β-淀粉样蛋白和 tau 蛋白病理
- 批准号:
8976888 - 财政年份:2015
- 资助金额:
$ 22.43万 - 项目类别:
Flavonoid-diosmin modulation of Abeta and tau pathologies through GSK-3 signaling
类黄酮-地奥司明通过 GSK-3 信号传导调节 Abeta 和 tau 病理学
- 批准号:
8627446 - 财政年份:2014
- 资助金额:
$ 22.43万 - 项目类别:
Octyl gallate (OG) and Promotion of non-amyloidogenic processing of APP
没食子酸辛酯 (OG) 和促进 APP 的非淀粉样蛋白加工
- 批准号:
8803251 - 财政年份:2013
- 资助金额:
$ 22.43万 - 项目类别:
Octyl gallate (OG) and Promotion of non-amyloidogenic processing of APP
没食子酸辛酯 (OG) 和促进 APP 的非淀粉样蛋白加工
- 批准号:
8441038 - 财政年份:2013
- 资助金额:
$ 22.43万 - 项目类别:
IL-6-mediated Jak2/Stat3 signaling and Brain Development
IL-6 介导的 Jak2/Stat3 信号传导与大脑发育
- 批准号:
7985709 - 财政年份:2010
- 资助金额:
$ 22.43万 - 项目类别:
IL-6-mediated Jak2/Stat3 signaling and Brain Development
IL-6 介导的 Jak2/Stat3 信号传导与大脑发育
- 批准号:
8135535 - 财政年份:2010
- 资助金额:
$ 22.43万 - 项目类别:
Implication of HUCBC: a novel therapeutic strategy for Alzheimer's disease
HUCBC 的意义:阿尔茨海默病的一种新治疗策略
- 批准号:
8505320 - 财政年份:2009
- 资助金额:
$ 22.43万 - 项目类别:
Implication of HUCBC: a novel therapeutic strategy for Alzheimer's disease
HUCBC 的意义:阿尔茨海默病的一种新治疗策略
- 批准号:
8305549 - 财政年份:2009
- 资助金额:
$ 22.43万 - 项目类别:
Statin modulation of immunotherapy for Alzheimer disease
他汀类药物调节阿尔茨海默病免疫疗法
- 批准号:
7681379 - 财政年份:2009
- 资助金额:
$ 22.43万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 22.43万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 22.43万 - 项目类别:
Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 22.43万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 22.43万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 22.43万 - 项目类别:
Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 22.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 22.43万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 22.43万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 22.43万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 22.43万 - 项目类别:
Research Grant














{{item.name}}会员




